Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate

By Goetsch L.   Plotnicky-Gilquin H.   Champion T.   Beck A.   Corvaa N.   Stahl S.   Bonnefoy J.-Y.   Nguyen T.N.   Power U.F.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2735-2742

Elsevier

Access to resources Recommend Favorite

DDA adjuvant induces a mixed Th1/Th2 immune response when associated with BBG2Na, a respiratory syncytial virus potential vaccine

By Klinguer-Hamour C.   Libon C.   Plotnicky-Gilquin H.   Bussat M.-C.   Revy L.   Nguyen T.   Bonnefoy J.-Y.   Corvaa N.   Beck A.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2743-2751

Elsevier

Access to resources Recommend Favorite

The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B

By Power U.F.   Plotnicky H.   Blaecke A.   Nguyen T.N.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 168-176

Elsevier

Access to resources Recommend Favorite

Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine

By Neuzil K.M.   Johnson J.E.   Tang Y.-W.   Prieels J.-P.   Slaoui M.   Gar N.   Graham B.S.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 525-532

Elsevier

Access to resources Recommend Favorite

Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates

By Jin H.   Cheng X.   Traina-Dorge V.L.   Park H.J.   Zhou H.   Soike K.   Kemble G.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3647-3652

Elsevier

Access to resources Recommend Favorite